0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Achalasia Treatment Market Research Report 2024
Published Date: June 2024
|
Report Code: QYRE-Auto-3X12660
Home | Market Reports | Health| Health Conditions
Global Achalasia Treatment Market Research Report 2022
BUY CHAPTERS

Global Achalasia Treatment Market Research Report 2024

Code: QYRE-Auto-3X12660
Report
June 2024
Pages:73
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Achalasia Treatment Market

Achalasia is a rare disorder that makes it difficult for food and liquid to pass from the swallowing tube connecting your mouth and stomach (esophagus) into your stomach. Achalasia occurs when nerves in the esophagus become damaged.
The global Achalasia Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Achalasia Treatment is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Achalasia Treatment is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Achalasia Treatment in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Achalasia Treatment include Bausch Health US LLC, Pfizer, Accordhealthcare, AdvaCare Pharma, Merz Therapeutics, Galderma, Zydus Pharmaceuticals (USA) Inc, Teva pharmaceutical industries ltd and Ohio State Medical Center, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Achalasia Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Achalasia Treatment.

Report Scope

The Achalasia Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Achalasia Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Achalasia Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Achalasia Treatment Market Report

Report Metric Details
Report Name Achalasia Treatment Market
Segment by Type
  • Calcium Channel Blockers (CCBs)
  • Nifedipine
  • Botulinum Toxin Injection
  • Others
Segment by Application
  • Hospitals
  • Retail Pharmacy
  • Online Pharmacy
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bausch Health US LLC, Pfizer, Accordhealthcare, AdvaCare Pharma, Merz Therapeutics, Galderma, Zydus Pharmaceuticals (USA) Inc, Teva pharmaceutical industries ltd, Ohio State Medical Center
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Achalasia Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Achalasia Treatment Market report?

Ans: The main players in the Achalasia Treatment Market are Bausch Health US LLC, Pfizer, Accordhealthcare, AdvaCare Pharma, Merz Therapeutics, Galderma, Zydus Pharmaceuticals (USA) Inc, Teva pharmaceutical industries ltd, Ohio State Medical Center

What are the Application segmentation covered in the Achalasia Treatment Market report?

Ans: The Applications covered in the Achalasia Treatment Market report are Hospitals, Retail Pharmacy, Online Pharmacy

What are the Type segmentation covered in the Achalasia Treatment Market report?

Ans: The Types covered in the Achalasia Treatment Market report are Calcium Channel Blockers (CCBs), Nifedipine, Botulinum Toxin Injection, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Achalasia Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Calcium Channel Blockers (CCBs)
1.2.3 Nifedipine
1.2.4 Botulinum Toxin Injection
1.2.5 Others
1.3 Market by Application
1.3.1 Global Achalasia Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Achalasia Treatment Market Perspective (2019-2030)
2.2 Achalasia Treatment Growth Trends by Region
2.2.1 Global Achalasia Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Achalasia Treatment Historic Market Size by Region (2019-2024)
2.2.3 Achalasia Treatment Forecasted Market Size by Region (2025-2030)
2.3 Achalasia Treatment Market Dynamics
2.3.1 Achalasia Treatment Industry Trends
2.3.2 Achalasia Treatment Market Drivers
2.3.3 Achalasia Treatment Market Challenges
2.3.4 Achalasia Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Achalasia Treatment Players by Revenue
3.1.1 Global Top Achalasia Treatment Players by Revenue (2019-2024)
3.1.2 Global Achalasia Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Achalasia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Achalasia Treatment Revenue
3.4 Global Achalasia Treatment Market Concentration Ratio
3.4.1 Global Achalasia Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Achalasia Treatment Revenue in 2023
3.5 Achalasia Treatment Key Players Head office and Area Served
3.6 Key Players Achalasia Treatment Product Solution and Service
3.7 Date of Enter into Achalasia Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Achalasia Treatment Breakdown Data by Type
4.1 Global Achalasia Treatment Historic Market Size by Type (2019-2024)
4.2 Global Achalasia Treatment Forecasted Market Size by Type (2025-2030)
5 Achalasia Treatment Breakdown Data by Application
5.1 Global Achalasia Treatment Historic Market Size by Application (2019-2024)
5.2 Global Achalasia Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Achalasia Treatment Market Size (2019-2030)
6.2 North America Achalasia Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Achalasia Treatment Market Size by Country (2019-2024)
6.4 North America Achalasia Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Achalasia Treatment Market Size (2019-2030)
7.2 Europe Achalasia Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Achalasia Treatment Market Size by Country (2019-2024)
7.4 Europe Achalasia Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Achalasia Treatment Market Size (2019-2030)
8.2 Asia-Pacific Achalasia Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Achalasia Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Achalasia Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Achalasia Treatment Market Size (2019-2030)
9.2 Latin America Achalasia Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Achalasia Treatment Market Size by Country (2019-2024)
9.4 Latin America Achalasia Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Achalasia Treatment Market Size (2019-2030)
10.2 Middle East & Africa Achalasia Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Achalasia Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Achalasia Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bausch Health US LLC
11.1.1 Bausch Health US LLC Company Detail
11.1.2 Bausch Health US LLC Business Overview
11.1.3 Bausch Health US LLC Achalasia Treatment Introduction
11.1.4 Bausch Health US LLC Revenue in Achalasia Treatment Business (2019-2024)
11.1.5 Bausch Health US LLC Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Achalasia Treatment Introduction
11.2.4 Pfizer Revenue in Achalasia Treatment Business (2019-2024)
11.2.5 Pfizer Recent Development
11.3 Accordhealthcare
11.3.1 Accordhealthcare Company Detail
11.3.2 Accordhealthcare Business Overview
11.3.3 Accordhealthcare Achalasia Treatment Introduction
11.3.4 Accordhealthcare Revenue in Achalasia Treatment Business (2019-2024)
11.3.5 Accordhealthcare Recent Development
11.4 AdvaCare Pharma
11.4.1 AdvaCare Pharma Company Detail
11.4.2 AdvaCare Pharma Business Overview
11.4.3 AdvaCare Pharma Achalasia Treatment Introduction
11.4.4 AdvaCare Pharma Revenue in Achalasia Treatment Business (2019-2024)
11.4.5 AdvaCare Pharma Recent Development
11.5 Merz Therapeutics
11.5.1 Merz Therapeutics Company Detail
11.5.2 Merz Therapeutics Business Overview
11.5.3 Merz Therapeutics Achalasia Treatment Introduction
11.5.4 Merz Therapeutics Revenue in Achalasia Treatment Business (2019-2024)
11.5.5 Merz Therapeutics Recent Development
11.6 Galderma
11.6.1 Galderma Company Detail
11.6.2 Galderma Business Overview
11.6.3 Galderma Achalasia Treatment Introduction
11.6.4 Galderma Revenue in Achalasia Treatment Business (2019-2024)
11.6.5 Galderma Recent Development
11.7 Zydus Pharmaceuticals (USA) Inc
11.7.1 Zydus Pharmaceuticals (USA) Inc Company Detail
11.7.2 Zydus Pharmaceuticals (USA) Inc Business Overview
11.7.3 Zydus Pharmaceuticals (USA) Inc Achalasia Treatment Introduction
11.7.4 Zydus Pharmaceuticals (USA) Inc Revenue in Achalasia Treatment Business (2019-2024)
11.7.5 Zydus Pharmaceuticals (USA) Inc Recent Development
11.8 Teva pharmaceutical industries ltd
11.8.1 Teva pharmaceutical industries ltd Company Detail
11.8.2 Teva pharmaceutical industries ltd Business Overview
11.8.3 Teva pharmaceutical industries ltd Achalasia Treatment Introduction
11.8.4 Teva pharmaceutical industries ltd Revenue in Achalasia Treatment Business (2019-2024)
11.8.5 Teva pharmaceutical industries ltd Recent Development
11.9 Ohio State Medical Center
11.9.1 Ohio State Medical Center Company Detail
11.9.2 Ohio State Medical Center Business Overview
11.9.3 Ohio State Medical Center Achalasia Treatment Introduction
11.9.4 Ohio State Medical Center Revenue in Achalasia Treatment Business (2019-2024)
11.9.5 Ohio State Medical Center Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Achalasia Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Calcium Channel Blockers (CCBs)
    Table 3. Key Players of Nifedipine
    Table 4. Key Players of Botulinum Toxin Injection
    Table 5. Key Players of Others
    Table 6. Global Achalasia Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Achalasia Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Achalasia Treatment Market Size by Region (2019-2024) & (US$ Million)
    Table 9. Global Achalasia Treatment Market Share by Region (2019-2024)
    Table 10. Global Achalasia Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 11. Global Achalasia Treatment Market Share by Region (2025-2030)
    Table 12. Achalasia Treatment Market Trends
    Table 13. Achalasia Treatment Market Drivers
    Table 14. Achalasia Treatment Market Challenges
    Table 15. Achalasia Treatment Market Restraints
    Table 16. Global Achalasia Treatment Revenue by Players (2019-2024) & (US$ Million)
    Table 17. Global Achalasia Treatment Market Share by Players (2019-2024)
    Table 18. Global Top Achalasia Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Achalasia Treatment as of 2023)
    Table 19. Ranking of Global Top Achalasia Treatment Companies by Revenue (US$ Million) in 2023
    Table 20. Global 5 Largest Players Market Share by Achalasia Treatment Revenue (CR5 and HHI) & (2019-2024)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Achalasia Treatment Product Solution and Service
    Table 23. Date of Enter into Achalasia Treatment Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Achalasia Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 26. Global Achalasia Treatment Revenue Market Share by Type (2019-2024)
    Table 27. Global Achalasia Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 28. Global Achalasia Treatment Revenue Market Share by Type (2025-2030)
    Table 29. Global Achalasia Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 30. Global Achalasia Treatment Revenue Market Share by Application (2019-2024)
    Table 31. Global Achalasia Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 32. Global Achalasia Treatment Revenue Market Share by Application (2025-2030)
    Table 33. North America Achalasia Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 34. North America Achalasia Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 35. North America Achalasia Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 36. Europe Achalasia Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. Europe Achalasia Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 38. Europe Achalasia Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Asia-Pacific Achalasia Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 40. Asia-Pacific Achalasia Treatment Market Size by Region (2019-2024) & (US$ Million)
    Table 41. Asia-Pacific Achalasia Treatment Market Size by Region (2025-2030) & (US$ Million)
    Table 42. Latin America Achalasia Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 43. Latin America Achalasia Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Achalasia Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Achalasia Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 46. Middle East & Africa Achalasia Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 47. Middle East & Africa Achalasia Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 48. Bausch Health US LLC Company Detail
    Table 49. Bausch Health US LLC Business Overview
    Table 50. Bausch Health US LLC Achalasia Treatment Product
    Table 51. Bausch Health US LLC Revenue in Achalasia Treatment Business (2019-2024) & (US$ Million)
    Table 52. Bausch Health US LLC Recent Development
    Table 53. Pfizer Company Detail
    Table 54. Pfizer Business Overview
    Table 55. Pfizer Achalasia Treatment Product
    Table 56. Pfizer Revenue in Achalasia Treatment Business (2019-2024) & (US$ Million)
    Table 57. Pfizer Recent Development
    Table 58. Accordhealthcare Company Detail
    Table 59. Accordhealthcare Business Overview
    Table 60. Accordhealthcare Achalasia Treatment Product
    Table 61. Accordhealthcare Revenue in Achalasia Treatment Business (2019-2024) & (US$ Million)
    Table 62. Accordhealthcare Recent Development
    Table 63. AdvaCare Pharma Company Detail
    Table 64. AdvaCare Pharma Business Overview
    Table 65. AdvaCare Pharma Achalasia Treatment Product
    Table 66. AdvaCare Pharma Revenue in Achalasia Treatment Business (2019-2024) & (US$ Million)
    Table 67. AdvaCare Pharma Recent Development
    Table 68. Merz Therapeutics Company Detail
    Table 69. Merz Therapeutics Business Overview
    Table 70. Merz Therapeutics Achalasia Treatment Product
    Table 71. Merz Therapeutics Revenue in Achalasia Treatment Business (2019-2024) & (US$ Million)
    Table 72. Merz Therapeutics Recent Development
    Table 73. Galderma Company Detail
    Table 74. Galderma Business Overview
    Table 75. Galderma Achalasia Treatment Product
    Table 76. Galderma Revenue in Achalasia Treatment Business (2019-2024) & (US$ Million)
    Table 77. Galderma Recent Development
    Table 78. Zydus Pharmaceuticals (USA) Inc Company Detail
    Table 79. Zydus Pharmaceuticals (USA) Inc Business Overview
    Table 80. Zydus Pharmaceuticals (USA) Inc Achalasia Treatment Product
    Table 81. Zydus Pharmaceuticals (USA) Inc Revenue in Achalasia Treatment Business (2019-2024) & (US$ Million)
    Table 82. Zydus Pharmaceuticals (USA) Inc Recent Development
    Table 83. Teva pharmaceutical industries ltd Company Detail
    Table 84. Teva pharmaceutical industries ltd Business Overview
    Table 85. Teva pharmaceutical industries ltd Achalasia Treatment Product
    Table 86. Teva pharmaceutical industries ltd Revenue in Achalasia Treatment Business (2019-2024) & (US$ Million)
    Table 87. Teva pharmaceutical industries ltd Recent Development
    Table 88. Ohio State Medical Center Company Detail
    Table 89. Ohio State Medical Center Business Overview
    Table 90. Ohio State Medical Center Achalasia Treatment Product
    Table 91. Ohio State Medical Center Revenue in Achalasia Treatment Business (2019-2024) & (US$ Million)
    Table 92. Ohio State Medical Center Recent Development
    Table 93. Research Programs/Design for This Report
    Table 94. Key Data Information from Secondary Sources
    Table 95. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Achalasia Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Achalasia Treatment Market Share by Type: 2023 VS 2030
    Figure 3. Calcium Channel Blockers (CCBs) Features
    Figure 4. Nifedipine Features
    Figure 5. Botulinum Toxin Injection Features
    Figure 6. Others Features
    Figure 7. Global Achalasia Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 8. Global Achalasia Treatment Market Share by Application: 2023 VS 2030
    Figure 9. Hospitals Case Studies
    Figure 10. Retail Pharmacy Case Studies
    Figure 11. Online Pharmacy Case Studies
    Figure 12. Achalasia Treatment Report Years Considered
    Figure 13. Global Achalasia Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 14. Global Achalasia Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Achalasia Treatment Market Share by Region: 2023 VS 2030
    Figure 16. Global Achalasia Treatment Market Share by Players in 2023
    Figure 17. Global Top Achalasia Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Achalasia Treatment as of 2023)
    Figure 18. The Top 10 and 5 Players Market Share by Achalasia Treatment Revenue in 2023
    Figure 19. North America Achalasia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. North America Achalasia Treatment Market Share by Country (2019-2030)
    Figure 21. United States Achalasia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Canada Achalasia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Europe Achalasia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe Achalasia Treatment Market Share by Country (2019-2030)
    Figure 25. Germany Achalasia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. France Achalasia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. U.K. Achalasia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Italy Achalasia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Russia Achalasia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Nordic Countries Achalasia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Asia-Pacific Achalasia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Asia-Pacific Achalasia Treatment Market Share by Region (2019-2030)
    Figure 33. China Achalasia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Japan Achalasia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. South Korea Achalasia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Southeast Asia Achalasia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. India Achalasia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Australia Achalasia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Latin America Achalasia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Latin America Achalasia Treatment Market Share by Country (2019-2030)
    Figure 41. Mexico Achalasia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Brazil Achalasia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Middle East & Africa Achalasia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Middle East & Africa Achalasia Treatment Market Share by Country (2019-2030)
    Figure 45. Turkey Achalasia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Saudi Arabia Achalasia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Bausch Health US LLC Revenue Growth Rate in Achalasia Treatment Business (2019-2024)
    Figure 48. Pfizer Revenue Growth Rate in Achalasia Treatment Business (2019-2024)
    Figure 49. Accordhealthcare Revenue Growth Rate in Achalasia Treatment Business (2019-2024)
    Figure 50. AdvaCare Pharma Revenue Growth Rate in Achalasia Treatment Business (2019-2024)
    Figure 51. Merz Therapeutics Revenue Growth Rate in Achalasia Treatment Business (2019-2024)
    Figure 52. Galderma Revenue Growth Rate in Achalasia Treatment Business (2019-2024)
    Figure 53. Zydus Pharmaceuticals (USA) Inc Revenue Growth Rate in Achalasia Treatment Business (2019-2024)
    Figure 54. Teva pharmaceutical industries ltd Revenue Growth Rate in Achalasia Treatment Business (2019-2024)
    Figure 55. Ohio State Medical Center Revenue Growth Rate in Achalasia Treatment Business (2019-2024)
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
    Figure 58. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

RELATED REPORTS

Global Insulin Coolers Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19Z7671
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Ossicular Prostheses Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10V14317
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Defibrillator Accessories Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10O5919
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Septicemia Diagnostic Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4I19963
Thu Sep 18 00:00:00 UTC 2025

Add to Cart